Bioqual, Inc. (OTCMKTS:BIOQ – Get Free Report) dropped 1.7% during trading on Thursday . The company traded as low as $65.00 and last traded at $65.00. 200 shares were traded during trading, a decline of 42% from the average daily volume of 344 shares. The stock had previously closed at $66.10.
Bioqual Price Performance
The stock has a market cap of $58.11 million, a P/E ratio of -52.85 and a beta of -0.34. The company has a fifty day moving average of $67.14 and a 200 day moving average of $69.20.
Bioqual (OTCMKTS:BIOQ – Get Free Report) last posted its quarterly earnings data on Tuesday, October 22nd. The company reported ($0.76) EPS for the quarter. The firm had revenue of $11.77 million during the quarter. Bioqual had a negative return on equity of 2.87% and a negative net margin of 1.99%.
About Bioqual
Bioqual, Inc provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer.
See Also
- Five stocks we like better than Bioqual
- How Can Investors Benefit From After-Hours Trading
- 3 Legacy Tech Companies Reemerging as AI Leaders
- Upcoming IPO Stock Lockup Period, Explained
- Analysts’ Favorite Cybersecurity Stocks: 3 Top Picks
- The Risks of Owning Bonds
- Analysts Are Bullish: 3 Tech Giants With Upgraded Price Targets
Receive News & Ratings for Bioqual Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioqual and related companies with MarketBeat.com's FREE daily email newsletter.
